Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Sarcoma, Ewing × Dactinomycin × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Rhabdomyosarcoma, Embryonal 2 Rhabdomyosarcoma 2 Stage I Mixed Cell Type Kidney Wilms Tumor 1 Sarcoma, Ewing 1 Sarcoma, Alveolar Soft Part 1 Sarcoma 1 Rhabdomyosarcoma, Alveolar 1 Pleuropulmonary blastoma 1 Histiocytoma, Malignant Fibrous 1 Dermatofibrosarcoma 1

Interventions

Temozolomide 8 Vincristine 7 Irinotecan 6 Cyclophosphamide 6 Etoposide 5 Specimen Handling 4 Ifosfamide 4 Doxorubicin 4 regorafenib 3 Radiotherapy 3 Radiation 3 Magnetic Resonance Spectroscopy 3 ivosidenib 2 fludarabine 2 etoposide phosphate 2 cabozantinib 2 abemaciclib 2 X-Rays 2 Topotecan 2 Surgical Procedures, Operative 2 Sirolimus 2 Phantoms, Imaging 2 PM 01183 2 Melphalan 2 Eflornithine 2 Congresses as Topic 2 Biopsy 2 ulixertinib 1 tipifarnib 1 tazemetostat 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07194044 2026-03-16

METTSEO

H. Lee Moffitt Cancer Center and Research Institute

Phase 1 Recruiting

Sarcoma, Ewing

Data powered by HemOnc (CC BY 4.0) Colophon ⚡